Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease

NCT04397211 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1872

Last updated 2024-01-23

No results posted yet for this study

Summary

Comparison of Angiography-derived Fractional FLow Reserve And IntraVascular Ultrasound-guided Intervention Strategy for Clinical OUtcomes in Patients with CoRonary Artery Disease

Conditions

Interventions

PROCEDURE

Angiography-derived FFR

The percutaneous coronary intervention using drug-eluting stent will be indicated according to following criteria in the Angiography-derived FFR-guided strategy arm \*Criteria for revascularization: Angiography-derived FFR ≤ 0.80

PROCEDURE

IVUS

The percutaneous coronary intervention using drug-eluting stent will be indicated according to following criteria in the IVUS-guided strategy arm \*Criteria for revascularization: Minimum lumen area (MLA) ≤ 3mm2 or 3\< MLA ≤ 4mm2 \& Plaque burden \> 70%

Sponsors & Collaborators

  • Seoul National University Hospital

    collaborator OTHER
  • Affiliated Hangzhou First People's Hospital

    collaborator UNKNOWN
  • Wuhan University

    collaborator OTHER
  • Peking University Third Hospital

    collaborator OTHER
  • The Affiliated Hospital of Hangzhou Normal University

    collaborator OTHER
  • RenJi Hospital

    collaborator OTHER
  • Second Hospital of Shanxi Medical University

    collaborator OTHER
  • First Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER
  • Second Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER
  • Changxing People's Hospital

    collaborator OTHER
  • The Affiliated Hospital of Medical College, Ningbo University

    collaborator OTHER
  • Jinhua Central Hospital

    collaborator OTHER
  • Shandong University of Traditional Chinese Medicine

    collaborator OTHER
  • Dongyang People's Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Nanchang University

    collaborator OTHER
  • Jining First People's Hospital

    collaborator OTHER
  • Second Affiliated Hospital of Shantou University Medical College

    collaborator OTHER
  • Ulsan University Hospital

    collaborator OTHER
  • Huizhou Municipal Central Hospital

    collaborator OTHER
  • Zhejiang Greentown Cardiovascular Hospital

    collaborator OTHER
  • The Fourth People's Hospital of Jinan

    collaborator UNKNOWN
  • First Affiliated Hospital of Kunming Medical University

    collaborator OTHER
  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Jian'an Wang, MD, PhD · Second Affiliated Hospital, School of Medicine, Zhejiang University

  • Bon-Kwon Koo, MD, PhD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-29
Primary Completion
2024-09-30
Completion
2028-09-30

Countries

  • China
  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04397211 on ClinicalTrials.gov